Medicare provider payments and utilization data for Iowa (IA)
Iowa received $7.1B in total Medicare provider payments across 10 years of data.
The top specialty by spending is Ophthalmology, accounting for $106.5M in payments across 144 providers.
In 2023, 12.0K providers were actively billing Medicare in Iowa.
Annual Medicare spending grew 21% from 2014 to 2023.
AI-generated analysis based on Medicare payment data.
| Year | Payments | Services | Providers | YoY Change |
|---|---|---|---|---|
| 2014 | $634.6M | 18.5M | 10.3K | — |
| 2015 | $680.5M | 20.1M | 10.6K | +7.2% |
| 2016 | $663.8M | 19.8M | 10.8K | -2.4% |
| 2017 | $696.9M | 20.1M | 11.1K | +5.0% |
| 2018 | $713.9M | 20.4M | 11.4K | +2.4% |
| 2019 | $730.3M | 21.2M | 11.6K | +2.3% |
| 2020 | $666.5M | 19.4M | 11.4K | -8.7% |
| 2021 | $782.2M | 22.2M | 11.7K | +17.4% |
| 2022 | $741.4M | 21.4M | 11.9K | -5.2% |
| 2023 | $764.8M | 22.4M | 12.0K | +3.2% |
| Code | Description | Payments | Services | Providers |
|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | $67.7M | 925.0K | 4.7K |
| J2777 | Injection, faricimab-svoa, 0.1 mg | $38.1M | 1.3M | 23 |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | $37.7M | 727.6K | 4.7K |
| J0178 | Injection, aflibercept, 1 mg | $30.4M | 44.2K | 40 |
| J9271 | Injection, pembrolizumab, 1 mg | $24.4M | 571.1K | 27 |
| 66984 | Removal of cataract with insertion of prosthetic lens | $17.3M | 51.6K | 343 |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | $16.2M | 283.0K | 1.7K |
| J0897 | Injection, denosumab, 1 mg | $14.0M | 767.1K | 189 |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | $13.8M | 119.1K | 1.1K |
| 98941 | Chiropractic manipulative treatment, 3-4 spinal regions | $13.5M | 523.9K | 945 |
| A0427 | Ambulance service, advanced life support, emergency transport, level 1 (als 1 - emergency) | $12.0M | 31.3K | 143 |
| 92014 | Established patient complete exam of visual system | $10.0M | 136.2K | 504 |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | $9.5M | 108.4K | 905 |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | $9.4M | 556.0K | 986 |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | $9.3M | 92.4K | 1.9K |
| 91320 | Sarscv2 vac 30mcg trs-suc im | $9.2M | 71.9K | 458 |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | $8.8M | 62.2K | 583 |
| 99285 | Emergency department visit with high level of medical decision making | $8.6M | 69.1K | 502 |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | $8.4M | 111.3K | 570 |
| 97530 | Therapy procedure using functional activities | $8.1M | 340.7K | 843 |
| Specialty | Payments | Providers | Avg per Provider |
|---|---|---|---|
| Ophthalmology | $106.5M | 144 | $739.5K |
| Family Practice | $62.4M | 1.1K | $58.5K |
| Nurse Practitioner | $49.0M | 2.0K | $24.6K |
| Ambulatory Surgical Center | $35.5M | 27 | $1.3M |
| Mass Immunizer Roster Biller | $33.9M | 406 | $83.5K |
| Ambulance Service Provider | $30.2M | 232 | $130.3K |
| Physical Therapist in Private Practice | $29.7M | 909 | $32.7K |
| Diagnostic Radiology | $28.8M | 246 | $117.2K |
| Hematology-Oncology | $28.7M | 51 | $563.0K |
| Internal Medicine | $27.7M | 371 | $74.6K |
| Medical Oncology | $27.2M | 40 | $680.4K |
| Physician Assistant | $23.1M | 926 | $24.9K |
| Rheumatology | $20.1M | 39 | $515.8K |
| Orthopedic Surgery | $19.1M | 190 | $100.3K |
| Optometry | $18.1M | 451 | $40.2K |
| Chiropractic | $16.1M | 1.0K | $15.6K |
| Cardiology | $15.7M | 121 | $129.6K |
| Podiatry | $15.3M | 168 | $91.1K |
| Dermatology | $15.0M | 75 | $200.3K |
| Emergency Medicine | $11.0M | 314 | $35.1K |
| Hospitalist | $10.1M | 193 | $52.6K |
| Nephrology | $9.5M | 63 | $150.2K |
| Urology | $9.4M | 75 | $125.8K |
| Interventional Cardiology | $8.3M | 49 | $168.9K |
| Otolaryngology | $8.2M | 87 | $94.5K |
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.